Txoj Kev Siv Txoj Kev thiab Kev: Kev Koom Tes, Kev Sib Haum Xeeb thiab Yeej-Yeej
cov khoom

Cov khoom

Liraglutide CAS: 204656-20-2 Chaw Tsim Khoom

Liraglutide, ib hom lipopeptide thiab polypeptide, yog ib yam khoom sib piv ntawm tib neeg GLP-1 uas cov lysine residue ntawm qhov chaw 27 hloov los ntawm arginine thiab ib pawg hexadecanoyl txuas rau cov lysine seem ntawm glutamic acid spacer. Nws yog siv ua ke nrog kev noj zaub mov thiab kev tawm dag zog los txhim kho kev tswj glycemic rau cov neeg laus uas muaj hom 2 ntshav qab zib mellitus. Liraglutide ua haujlwm ua glucagon-zoo li peptide-1 receptor agonist thiab ua haujlwm ua tus neeg sawv cev neuroprotective.


Cov Lus Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Liraglutide yog ib hom tshuaj hypoglycemic tshiab uas ua rau AMP-activated protein kinase ua haujlwm kom ua rau insulin rhiab heev. Nws tsis yog tsuas yog muaj cov nyhuv hypoglycemic tseem ceeb xwb, tab sis kuj muaj cov haujlwm ntawm kev poob phaus, txo cov ntshav siab, thiab txhim kho cov ntshav lipid profile. Liraglutide, ib qho peptide zoo li glucagon-zoo li tib neeg-1 (GLP-1) receptor agonist, ua rau qeeb plab zom mov, ua rau kom txaus siab, thiab txo cov neeg mob noj mov, thaum txo lub hlwb lub siab xav noj mov thiab tso cai rau lub cev kom siv zog ntau ntxiv ua lub luag haujlwm hauv kev poob phaus; nws tiv thaiv lub siab los ntawm kev tsim cov piam thaj ntau dhau thiab txhawb kom lub txiav ua kom tsim cov insulin ntau dua los txo cov ntshav qab zib; ntxiv rau, liraglutide kuj muaj cov txiaj ntsig zoo rau lub plawv thiab lub raum.

Qauv Khoom

Phau Ntawv Nkauj 282(1)
260 (1)

Khoom Ntim:

Phau Ntawv Nkauj 283(1)

Cov Lus Qhia Ntxiv:

Kev sau ua ke C172H265N43O51
Kev Ntsuas 99%
Qhov tsos Hmoov dawb
CAS Nr. 204656-20-2
Ntim khoom 25KG
Lub Neej Txee 2 xyoos
Kev Khaws Cia Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj ISO.

  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb